J&J Medical Connect
SYMTUZA®

(darunavir/ cobicistat/ emtricitabine/ tenofovir alafenamide)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

SYMTUZA - Tablet Image

Last Updated: 08/07/2026

Summary

  • SYMTUZA® (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) tablets are supplied as yellow to yellowish-brown, capsule-shaped, film-coated tablets sized 22 mm x 11 mm, debossed with “8121” on one side and “JG” on the other side.1
  • An image of the SYMTUZA® tablet is provided for your reference.

TABLET INFORMATION

  • SYMTUZA® tablets are supplied as yellow to yellowish-brown, capsule-shaped, film-coated tablets sized 22 mm x 11 mm, debossed with “8121” on one side and “JG” on the other side.1
  • An image of the SYMTUZA® tablet is provided in Figure: SYMTUZA® Tablet Image.

SYMTUZA® Tablet Image

(not actual size)

References

1 Data on File. Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide. Company Core Data Sheet. Janssen Research & Development, LLC. EDMS-ERI-119231875; 2021.  

Would you like to clear and leave your conversation? Message history will be lost.